Skip to main content
European Innovation Council logo
European Innovation Council

Oxiflow: saving lives, treating brain aunerysm

Oxford Endovascular is developing a treatment for brain aneurysms. The company, which is a spin-out from Oxford University, have just raised $10 million (around €8 million)  to Engineer a medical device to prevent brain hemorrhage.

OxiFlow micro stent uses ‘origami engineering’, which enabled its structure to be reduced and subsequently enlarge

Vulpes Investment Management led the round, with the Additio Investment Group, Oxford Sciences Innovation PLC, Parkwalk Advisors, Perivoli Innovations, Oxford Investment Consultants, the University of Oxford and private individuals following on.

The Oxford University spin-out has previously won funding from the European Union’s Horizon 2020 SME instrument and the UK’s grant programme, Innovate UK.

Their OxiFlow micro stent was developed using ‘origami engineering’, which enabled its structure to be reduced and subsequently enlarged.

OxiFlow can be inserted into the brain blood vessels via minimally invasive groin access. It lies across the base of the aneurysm and causes it to shrink and heal. This ‘flow-diverter’ can be placed more accurately and safely than existing treatments, reducing the risk of complications and having to use multiple devices.


Press release: Oxford Endovascular Ltd raises $10m to develop its origami engineered medical device to prevent brain haemorrhage 

Check the project in the EIC datahub